schliessen

Filtern

 

Bibliotheken

Cover Image

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors

A population-based sample was studied to define immune abnormalities in individuals at risk of Type II (non-insulin-dependent) diabetes mellitus because of impaired glucose tolerance. A total of 1653 individuals aged 55 to 74 years participated in a population based survey in Southern Germany (KORA... Full description

Journal Title: Diabetologia 2002, Vol.45 (6), p.805-812
Main Author: MÜLLER, S
Other Authors: MARTIN, S , KOENIG, W , HANIFI-MOGHADDAM, P , RATHMANN, W , HAASTERT, B , GIANI, G , ILLIG, T , THORAND, B , KOLB, H
Format: Electronic Article Electronic Article
Language: English
Subjects:
Acute-Phase Proteins - metabolism
Aged
Biological and medical sciences
Blood Glucose - metabolism
Blood Pressure
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - immunology
Diabetes Mellitus, Type 2 - physiopathology
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Glucose Intolerance - blood
Glucose Intolerance - immunology
Glucose Intolerance - physiopathology
Glucose Tolerance Test
Humans
Interleukin-6 - blood
Lipids - blood
Male
Medical sciences
Receptors, Tumor Necrosis Factor - blood
Reference Values
Tumor Necrosis Factor-alpha - metabolism
Publisher: Berlin: Springer
ID: ISSN: 0012-186X
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_71882904
title: Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors
format: Article
creator:
  • MÜLLER, S
  • MARTIN, S
  • KOENIG, W
  • HANIFI-MOGHADDAM, P
  • RATHMANN, W
  • HAASTERT, B
  • GIANI, G
  • ILLIG, T
  • THORAND, B
  • KOLB, H
subjects:
  • Acute-Phase Proteins - metabolism
  • Aged
  • Biological and medical sciences
  • Blood Glucose - metabolism
  • Blood Pressure
  • Diabetes Mellitus, Type 2 - blood
  • Diabetes Mellitus, Type 2 - immunology
  • Diabetes Mellitus, Type 2 - physiopathology
  • Diabetes. Impaired glucose tolerance
  • Endocrine pancreas. Apud cells (diseases)
  • Endocrinopathies
  • Etiopathogenesis. Screening. Investigations. Target tissue resistance
  • Female
  • Glucose Intolerance - blood
  • Glucose Intolerance - immunology
  • Glucose Intolerance - physiopathology
  • Glucose Tolerance Test
  • Humans
  • Interleukin-6 - blood
  • Lipids - blood
  • Male
  • Medical sciences
  • Receptors, Tumor Necrosis Factor - blood
  • Reference Values
  • Tumor Necrosis Factor-alpha - metabolism
ispartof: Diabetologia, 2002, Vol.45 (6), p.805-812
description: A population-based sample was studied to define immune abnormalities in individuals at risk of Type II (non-insulin-dependent) diabetes mellitus because of impaired glucose tolerance. A total of 1653 individuals aged 55 to 74 years participated in a population based survey in Southern Germany (KORA Survey 2000). Those without a history of diabetes were subjected to an OGTT. Randomly selected subjects with IGT ( n=80) were compared with non-diabetic control subjects ( n=77) and patients with Type II diabetes ( n=152) of the same population-based sample after matching for age and sex. Immune parameters were analysed in serum with rigidly evaluated ELISA. Serum pro-inflammatory cytokine interleukin 6 (IL-6) concentrations were higher in subjects with IGT and Type II diabetes than in the control subjects (median 1.8 and 2.5 vs 0.8 pg/ml, p
language: eng
source:
identifier: ISSN: 0012-186X
fulltext: no_fulltext
issn:
  • 0012-186X
  • 1432-0428
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.460968
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_cross
recordidTN_cdi_proquest_miscellaneous_71882904
sourceformatXML
sourcesystemPC
sourcerecordid71882904
originalsourceidFETCH-LOGICAL-1400t-9df64195c04f2c3802d004b7bce294b274c10b401553321523220ac050a8d2d90
addsrcrecordideNp9kU-KFTEQh4MozvPpAdxINrqLVtLpf0sZHB0YdDOCu5BOV89EuzttKkE8jyfwIp7JvHkPBly4CkW--qVSH2PPJbyWAO0bApCqFgBKQKd6oR6wndRVqbTqHrLd4VrIrvlyxp4QfQWAqtbNY3YmlYS2VXrHfl0um_URR34zZxcIeQozRrs65J64JQrO21Tuf_h0y_3qIloqJWHMC3ehgGuKNvmwEg9TIRLGGfM3v_KG23UsjIh4k-e7FOtyQrHdlgy-xZDQl7YhJ76GxK8_Xog_v3mI3CfiER1uKUR6yh5NdiZ8djr37PPFu-vzD-Lq0_vL87dXQmqAJPpxarTsawd6Uq7qQI0AemgHh6rXg2q1kzBokHVdVUrWqlIKrIMabDeqsYc9e3XMLYN9z0jJLJ4czrNdMWQyrezKlkEXUB5BFwNRxMls0S82_jQSzMGMOZoxxYw5mDGq9Lw4hedhwfG-46SiAC9PgCVn5-ngwNM9V_7YN0XhnrX_PO58utt_0eDn_4zwF2ECqlw
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid71882904
display
typearticle
titleImpaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors
creatorMÜLLER, S ; MARTIN, S ; KOENIG, W ; HANIFI-MOGHADDAM, P ; RATHMANN, W ; HAASTERT, B ; GIANI, G ; ILLIG, T ; THORAND, B ; KOLB, H
creatorcontribMÜLLER, S ; MARTIN, S ; KOENIG, W ; HANIFI-MOGHADDAM, P ; RATHMANN, W ; HAASTERT, B ; GIANI, G ; ILLIG, T ; THORAND, B ; KOLB, H
descriptionA population-based sample was studied to define immune abnormalities in individuals at risk of Type II (non-insulin-dependent) diabetes mellitus because of impaired glucose tolerance. A total of 1653 individuals aged 55 to 74 years participated in a population based survey in Southern Germany (KORA Survey 2000). Those without a history of diabetes were subjected to an OGTT. Randomly selected subjects with IGT ( n=80) were compared with non-diabetic control subjects ( n=77) and patients with Type II diabetes ( n=152) of the same population-based sample after matching for age and sex. Immune parameters were analysed in serum with rigidly evaluated ELISA. Serum pro-inflammatory cytokine interleukin 6 (IL-6) concentrations were higher in subjects with IGT and Type II diabetes than in the control subjects (median 1.8 and 2.5 vs 0.8 pg/ml, p<0.0001). Soluble IL-6 receptors potentiate IL-6 bioactivity and their concentrations were mildly increased in Type II diabetes ( p<0.05). These immune changes seem relevant because IL-6 dependent acute-phase proteins C-reactive protein, serum amyloid A protein and fibrinogen were also increased in IGT and Type II diabetes. Circulating concentrations of TNF-alpha and its two receptors sTNF-R60 and sTNF-R80 were not increased in IGT subjects compared with the control subjects. Our study shows systemic up-regulation of selected inflammatory mediators in patients with Type II diabetes and IGT. The pattern observed is non-random and fits with an IL-6 associated rather than TNF-alpha associated response.
identifier
0ISSN: 0012-186X
1EISSN: 1432-0428
2DOI: 10.1007/s00125-002-0829-2
3PMID: 12107724
languageeng
publisherBerlin: Springer
subjectAcute-Phase Proteins - metabolism ; Aged ; Biological and medical sciences ; Blood Glucose - metabolism ; Blood Pressure ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - immunology ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Glucose Intolerance - blood ; Glucose Intolerance - immunology ; Glucose Intolerance - physiopathology ; Glucose Tolerance Test ; Humans ; Interleukin-6 - blood ; Lipids - blood ; Male ; Medical sciences ; Receptors, Tumor Necrosis Factor - blood ; Reference Values ; Tumor Necrosis Factor-alpha - metabolism
ispartofDiabetologia, 2002, Vol.45 (6), p.805-812
rights2003 INIST-CNRS
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-1400t-9df64195c04f2c3802d004b7bce294b274c10b401553321523220ac050a8d2d90
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14009600$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12107724$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0MÜLLER, S
1MARTIN, S
2KOENIG, W
3HANIFI-MOGHADDAM, P
4RATHMANN, W
5HAASTERT, B
6GIANI, G
7ILLIG, T
8THORAND, B
9KOLB, H
title
0Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors
1Diabetologia
addtitleDiabetologia
descriptionA population-based sample was studied to define immune abnormalities in individuals at risk of Type II (non-insulin-dependent) diabetes mellitus because of impaired glucose tolerance. A total of 1653 individuals aged 55 to 74 years participated in a population based survey in Southern Germany (KORA Survey 2000). Those without a history of diabetes were subjected to an OGTT. Randomly selected subjects with IGT ( n=80) were compared with non-diabetic control subjects ( n=77) and patients with Type II diabetes ( n=152) of the same population-based sample after matching for age and sex. Immune parameters were analysed in serum with rigidly evaluated ELISA. Serum pro-inflammatory cytokine interleukin 6 (IL-6) concentrations were higher in subjects with IGT and Type II diabetes than in the control subjects (median 1.8 and 2.5 vs 0.8 pg/ml, p<0.0001). Soluble IL-6 receptors potentiate IL-6 bioactivity and their concentrations were mildly increased in Type II diabetes ( p<0.05). These immune changes seem relevant because IL-6 dependent acute-phase proteins C-reactive protein, serum amyloid A protein and fibrinogen were also increased in IGT and Type II diabetes. Circulating concentrations of TNF-alpha and its two receptors sTNF-R60 and sTNF-R80 were not increased in IGT subjects compared with the control subjects. Our study shows systemic up-regulation of selected inflammatory mediators in patients with Type II diabetes and IGT. The pattern observed is non-random and fits with an IL-6 associated rather than TNF-alpha associated response.
subject
0Acute-Phase Proteins - metabolism
1Aged
2Biological and medical sciences
3Blood Glucose - metabolism
4Blood Pressure
5Diabetes Mellitus, Type 2 - blood
6Diabetes Mellitus, Type 2 - immunology
7Diabetes Mellitus, Type 2 - physiopathology
8Diabetes. Impaired glucose tolerance
9Endocrine pancreas. Apud cells (diseases)
10Endocrinopathies
11Etiopathogenesis. Screening. Investigations. Target tissue resistance
12Female
13Glucose Intolerance - blood
14Glucose Intolerance - immunology
15Glucose Intolerance - physiopathology
16Glucose Tolerance Test
17Humans
18Interleukin-6 - blood
19Lipids - blood
20Male
21Medical sciences
22Receptors, Tumor Necrosis Factor - blood
23Reference Values
24Tumor Necrosis Factor-alpha - metabolism
issn
00012-186X
11432-0428
fulltextfalse
rsrctypearticle
creationdate2002
recordtypearticle
recordideNp9kU-KFTEQh4MozvPpAdxINrqLVtLpf0sZHB0YdDOCu5BOV89EuzttKkE8jyfwIp7JvHkPBly4CkW--qVSH2PPJbyWAO0bApCqFgBKQKd6oR6wndRVqbTqHrLd4VrIrvlyxp4QfQWAqtbNY3YmlYS2VXrHfl0um_URR34zZxcIeQozRrs65J64JQrO21Tuf_h0y_3qIloqJWHMC3ehgGuKNvmwEg9TIRLGGfM3v_KG23UsjIh4k-e7FOtyQrHdlgy-xZDQl7YhJ76GxK8_Xog_v3mI3CfiER1uKUR6yh5NdiZ8djr37PPFu-vzD-Lq0_vL87dXQmqAJPpxarTsawd6Uq7qQI0AemgHh6rXg2q1kzBokHVdVUrWqlIKrIMabDeqsYc9e3XMLYN9z0jJLJ4czrNdMWQyrezKlkEXUB5BFwNRxMls0S82_jQSzMGMOZoxxYw5mDGq9Lw4hedhwfG-46SiAC9PgCVn5-ngwNM9V_7YN0XhnrX_PO58utt_0eDn_4zwF2ECqlw
startdate2002
enddate2002
creator
0MÜLLER, S
1MARTIN, S
2KOENIG, W
3HANIFI-MOGHADDAM, P
4RATHMANN, W
5HAASTERT, B
6GIANI, G
7ILLIG, T
8THORAND, B
9KOLB, H
generalSpringer
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
97X8
sort
creationdate2002
titleImpaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors
authorMÜLLER, S ; MARTIN, S ; KOENIG, W ; HANIFI-MOGHADDAM, P ; RATHMANN, W ; HAASTERT, B ; GIANI, G ; ILLIG, T ; THORAND, B ; KOLB, H
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1400t-9df64195c04f2c3802d004b7bce294b274c10b401553321523220ac050a8d2d90
rsrctypearticles
prefilterarticles
languageeng
creationdate2002
topic
0Acute-Phase Proteins - metabolism
1Aged
2Biological and medical sciences
3Blood Glucose - metabolism
4Blood Pressure
5Diabetes Mellitus, Type 2 - blood
6Diabetes Mellitus, Type 2 - immunology
7Diabetes Mellitus, Type 2 - physiopathology
8Diabetes. Impaired glucose tolerance
9Endocrine pancreas. Apud cells (diseases)
10Endocrinopathies
11Etiopathogenesis. Screening. Investigations. Target tissue resistance
12Female
13Glucose Intolerance - blood
14Glucose Intolerance - immunology
15Glucose Intolerance - physiopathology
16Glucose Tolerance Test
17Humans
18Interleukin-6 - blood
19Lipids - blood
20Male
21Medical sciences
22Receptors, Tumor Necrosis Factor - blood
23Reference Values
24Tumor Necrosis Factor-alpha - metabolism
toplevelpeer_reviewed
creatorcontrib
0MÜLLER, S
1MARTIN, S
2KOENIG, W
3HANIFI-MOGHADDAM, P
4RATHMANN, W
5HAASTERT, B
6GIANI, G
7ILLIG, T
8THORAND, B
9KOLB, H
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8MEDLINE - Academic
jtitleDiabetologia
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0MÜLLER, S
1MARTIN, S
2KOENIG, W
3HANIFI-MOGHADDAM, P
4RATHMANN, W
5HAASTERT, B
6GIANI, G
7ILLIG, T
8THORAND, B
9KOLB, H
formatjournal
genrearticle
ristypeJOUR
atitleImpaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors
jtitleDiabetologia
addtitleDiabetologia
date2002
risdate2002
volume45
issue6
spage805
epage812
pages805-812
issn0012-186X
eissn1432-0428
abstractA population-based sample was studied to define immune abnormalities in individuals at risk of Type II (non-insulin-dependent) diabetes mellitus because of impaired glucose tolerance. A total of 1653 individuals aged 55 to 74 years participated in a population based survey in Southern Germany (KORA Survey 2000). Those without a history of diabetes were subjected to an OGTT. Randomly selected subjects with IGT ( n=80) were compared with non-diabetic control subjects ( n=77) and patients with Type II diabetes ( n=152) of the same population-based sample after matching for age and sex. Immune parameters were analysed in serum with rigidly evaluated ELISA. Serum pro-inflammatory cytokine interleukin 6 (IL-6) concentrations were higher in subjects with IGT and Type II diabetes than in the control subjects (median 1.8 and 2.5 vs 0.8 pg/ml, p<0.0001). Soluble IL-6 receptors potentiate IL-6 bioactivity and their concentrations were mildly increased in Type II diabetes ( p<0.05). These immune changes seem relevant because IL-6 dependent acute-phase proteins C-reactive protein, serum amyloid A protein and fibrinogen were also increased in IGT and Type II diabetes. Circulating concentrations of TNF-alpha and its two receptors sTNF-R60 and sTNF-R80 were not increased in IGT subjects compared with the control subjects. Our study shows systemic up-regulation of selected inflammatory mediators in patients with Type II diabetes and IGT. The pattern observed is non-random and fits with an IL-6 associated rather than TNF-alpha associated response.
copBerlin
pubSpringer
pmid12107724
doi10.1007/s00125-002-0829-2
oafree_for_read